Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …

We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …

Human immunodeficiency virus (HIV) has a small genome and therefore relies heavily on
the host cellular machinery to replicate. Identifying which host proteins and complexes come …

SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…

Objectives: The explosive and ongoing injecting drug use-related HIV-1 epidemic in Vancouver
continues to receive international attention. This study was conducted to determine how …

Objective To examine the relation between plasma HIV-1 RNA concentrations in the community
and HIV incidence among injecting drug users. Design Prospective cohort study. Setting …

Safer injection facilities provide medical supervision for illicit drug injections. We aimed to
examine factors associated with syringe sharing in a community-recruited cohort of illicit …

BACKGROUND: Non-fatal overdose is a major determinant of morbidity among injection drug
users (IDU). We sought to evaluate factors associated with non-fatal overdose among IDU …

Background: North America's first medically supervised safer injecting facility for illicit injection
drug users was opened in Vancouver on Sept. 22, 2003. Although similar facilities exist in …

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …